CVSCVS HEALTH CorpLarge cap · $135.12B · FY ending 2025-12-31
$105.90+1.68% · 2026-07-13 · EOD
45/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality24
thin moat · ROIC 3%Value33
P/E 76.2 · 100% of 12-mo rangeMomentum75
golden · price above 200-daySmart Money48
quiet · 2 funds · 0P/2S insidersBullish stackGolden crossAbove 200-day
vs S&P 500+22.7%
6-mo excess Trailing performance1M +8.0%
3M +33.5%
6M +31.4%
YTD +32.2%
1Y +61.4%
P/E vs its last 12 months (our price history): 42.3 low → 76.2 high
Current price sits at the 100th percentile of that window — near the top (richer). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
No clear moat — ROIC 3%
Piotroski F6/9
fundamental strength Altman ZGrey
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 19%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio196.6%
above earnings Shareholder yield2.5%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Quiet0P / 2S insiders · 2 funds hold · 0 Congress buys
Recent insidersROBBINS LARRY · DirectorSELL$317.5M
Mandadi Tilak · EVP, Chief Exp & Tech OfficerSELL$6.2M
Fund holders (13F)Pzena Investment Management (Richard Pzena)$989.2M3.2% of book
Fairfax Financial (Prem Watsa)$194.8M10.0% of book
CongressDwight EvansSELL2025-11-21
Bhealth · 79/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.